ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,676 | -66.0% | 81,197 | -55.4% | 0.00% | -100.0% |
| Q2 2023 | $334,626 | +80.7% | 181,862 | +138.6% | 0.00% | 0.0% |
| Q1 2023 | $185,215 | +351.7% | 76,220 | +288.8% | 0.00% | – |
| Q2 2022 | $41,000 | +10.8% | 19,603 | +66.2% | 0.00% | – |
| Q2 2021 | $37,000 | -82.5% | 11,793 | -84.7% | 0.00% | -100.0% |
| Q1 2019 | $211,000 | +106.9% | 77,313 | +111.4% | 0.00% | +100.0% |
| Q4 2018 | $102,000 | -67.4% | 36,572 | -51.9% | 0.00% | -66.7% |
| Q3 2018 | $313,000 | – | 75,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,392,642 | $6,939,000 | 11.21% |
| VIEX Capital Advisors, LLC | 1,435,130 | $4,162,000 | 7.44% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $15,010,000 | 6.29% |
| Potomac Capital Management, Inc. | 496,805 | $1,441,000 | 1.24% |
| AMH Equity Ltd | 30,000 | $87,000 | 0.09% |
| Corsair Capital Management | 75,026 | $218,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $730,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $74,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 539,954 | $1,566,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 25,777 | $75,000 | 0.02% |